History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

Buprenorphine-based medications were first approved by the United States Food and Drug Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) as the condition is presently known. This regulatory milestone was the outcome of 36 years of research and development, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidbreder, Christian, Fudala, Paul J., Greenwald, Mark K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040330/
https://www.ncbi.nlm.nih.gov/pubmed/36994370
http://dx.doi.org/10.1016/j.dadr.2023.100133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040330/
https://www.ncbi.nlm.nih.gov/pubmed/36994370
http://dx.doi.org/10.1016/j.dadr.2023.100133

Ejemplares similares